FOA Title: 
Notice of Special Interest for Small Business Research in Genomics
Grant Type: 
NOT-GM-19-041
Primary IC: 
NIGMS
Release Date: 
May 15 2019
Expiration Date: 
N/A
AC Source: 
N/A
Purpose: 
Notice Special Interest Small Business Research Genomics Notice Number: NOT-GM-19-041 Key Dates Release Date: 15, 2019 Related Announcements PAR-18-779 - Novel Genomic Technology Development R43/R44 Clinical Trial Allowed) PAR-19-061 -Computational Genomics Data Science Opportunities Small Business R43/R44 Clinical Trial Allowed) PA-19-043 - Novel Approaches Relating Genetic Variation Function Disease R43/R44 Clinical Trial Allowed) PA-19-034 - Commercializing Understudied Proteins the Illuminating Druggable Genome Project IDG) R43/R44 Clinical Trial Allowed) Issued National Institute General Medical Sciences NIGMS) Purpose National Institute General Medical Sciences NIGMS) issuing Notice highlight interest receiving Small Business Innovation Research SBIR) Small Business Technology Transfer STTR) grant applications focused the following areas: Improvement methodology technology) genetic analysis e.g., gene expression, probes), including procedures the separation analysis nucleic acids proteins these relate genetic problems. Improvement procedures statistical, computational, laboratory) the analysis gene flow gene dynamics human populations. Development improved vectors gene transfer. Development tools technologies detect monitor complex human phenotypes traits. Improvement procedures statistical, computational, laboratory) the high- medium-throughput analysis gene expression patterns regulatory networks. Development improvement methods high throughput detection epigenomic changes. Development improved novel methodology structure/function analysis very large macromolecular complexes involved transmission expression genetic material. Development new innovative tools methods bioinformatics computational biology. Development tools technologies a biomedical data science ecosystem biomedical research. Technologies findability, interconnectivity, interoperability biomedical data sets resources, integration existing data management tools development new ones, universalization innovative algorithms tools. Development ontologies modules useful combining mining databases containing genotype phenotype information order discover correlations drug effects, either therapeutic adverse. Development methods strategies characterize function kinases, ion channels G-protein coupled receptors development cell signaling molecules signaling intermediates, particularly those related G-protein coupled receptors ultimately leading the commercialization understudied proteins identified the Illuminating Druggable Genome" project. Application Submission Information Notice applies application due dates the dates indicated below subsequent due dates through expiration date the FOA. following funding opportunity announcements FOAs) must used submissions this initiative. Although NIGMS not listed a Participating Organization the FOAs listed below, applications this initiative be accepted. Activity Code FOA First Available Due Date R43/R44 PAR-18-779, Novel Genomic Technology Development R43/R44 Clinical Trial Allowed) September 5, 2019 R43/R44 PAR-19-061, Computational Genomics Data Science Opportunities Small Business R43/R44 Clinical Trial Allowed) September 5, 2019 R43/R44 PA-19-043, Novel Approaches Relating Genetic Variation Function Disease R43/R44 Clinical Trial Allowed) September 5, 2019 R43/R44 PA-19-034, Commercializing Understudied Proteins the Illuminating Druggable Genome Project IDG) R43/R44 Clinical Trial Allowed) September 5, 2019 instructions the SF424 R&R) Application Guide and listed funding opportunity announcements must followed, the following additions: funding consideration, applicants must include NOT-GM-19-041" (without quotation marks) the Agency Routing Identifier field box 4B) the SF424 R&R form. Applications without information box 4B not considered this initiative. Applications non-responsive terms this Notice be withdrawn. Inquiries Please direct inquiries to: Scientific/Research Contact: Dmitriy Krepkiy, Ph.D. National Institute General Medical Sciences Email: dmitriy.krepkiy@nih.gov Financial Grants Management Contact: Brian Iglesias National Institute General Medical Sciences Email: iglesiab@mail.nih.gov